TMDX - צמיחת הכנסות ב-12 חודשים נגררים TransMedics Group

TransMedics Group (TMDX) aims for total control over transplant logistics in the US through its own aviation network and AI systems. High business scalability is driven by the sale of high-margin consumables. Year-over-year sales growth (over 4 quarters) demonstrates revenue dynamics, where 28.20 represents the current metric level. Rapid commercial growth renders the company immune to any macroeconomic fluctuations.
transmedics.com (TMDX) - פילוחי מדדים ודוחות פיננסיים

TTM revenue growth measures the aggregate change in sales over the last twelve months, allowing for the elimination of short-term volatility to determine the actual phase of business development. For TransMedics Group (TMDX), this indicator confirms the effectiveness of the expansion of organ preservation systems and the adoption of technologies by clinics. By analyzing the annual revenue dynamics via the TTM metric, an investor can see the scaling pace of the logistics network. Stable acceleration confirms the fundamental resilience of the company.